GB2486842A - Adaptor for connecting a sampling plate to a measurement device - Google Patents

Adaptor for connecting a sampling plate to a measurement device Download PDF

Info

Publication number
GB2486842A
GB2486842A GB1205054.8A GB201205054A GB2486842A GB 2486842 A GB2486842 A GB 2486842A GB 201205054 A GB201205054 A GB 201205054A GB 2486842 A GB2486842 A GB 2486842A
Authority
GB
United Kingdom
Prior art keywords
adaptor
sampling plate
sample
measurement
zone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB1205054.8A
Other versions
GB201205054D0 (en
GB2486842B (en
Inventor
Matthew Robert Bryan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MENAI MEDICAL TECHNOLOGIES Ltd
Original Assignee
MENAI MEDICAL TECHNOLOGIES Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MENAI MEDICAL TECHNOLOGIES Ltd filed Critical MENAI MEDICAL TECHNOLOGIES Ltd
Priority to GB1205054.8A priority Critical patent/GB2486842B/en
Publication of GB201205054D0 publication Critical patent/GB201205054D0/en
Publication of GB2486842A publication Critical patent/GB2486842A/en
Priority to HK12113388.9A priority patent/HK1172683A1/en
Application granted granted Critical
Publication of GB2486842B publication Critical patent/GB2486842B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28Electrolytic cell components
    • G01N27/30Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G01N27/3273Devices therefor, e.g. test element readers, circuitry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/4875Details of handling test elements, e.g. dispensing or storage, not specific to a particular test method
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/04Constructional details of apparatus
    • A61B2560/0443Modular apparatus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/04Constructional details of apparatus
    • A61B2560/0456Apparatus provided with a docking unit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0295Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/08Sensors provided with means for identification, e.g. barcodes or memory chips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/12Manufacturing methods specially adapted for producing sensors for in-vivo measurements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/22Arrangements of medical sensors with cables or leads; Connectors or couplings specifically adapted for medical sensors
    • A61B2562/225Connectors or couplings
    • A61B2562/226Connectors or couplings comprising means for identifying the connector, e.g. to prevent incorrect connection to socket
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/22Arrangements of medical sensors with cables or leads; Connectors or couplings specifically adapted for medical sensors
    • A61B2562/225Connectors or couplings
    • A61B2562/227Sensors with electrical connectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Electrochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

An adaptor 300 for connecting a sampling plate 100 for receiving a liquid substrate to be tested to a measurement device 200 operable to display, or to both measure and display, one or more selected properties of the liquid substrate preferably the glucose levels in a blood sample. Preferably, the adaptor 300 comprises a processor for managing two-way communication between the sampling plate 100 and the measurement device 200, which are otherwise incompatible. The sampling plate 100 may comprise a sample zone with at least two discrete testing zones, wherein the sample zone is arranged, in use to separate the liquid substrate into at least two discrete samples, such that each sample occupies a respective testing zone. Preferably, the measurement device 200 is operable to communicate with the sampling plate 100 to measure and/or display one or more selected properties of the liquid substrate wherein the adaptor 300 may comprise an information tag which communicates information about the sampling plate100 to the measurement device 200. The adaptor 300 may also be arranged to be connectable with a computer preferably via a USB port.

Description

SAMPLE MEASUREMENT SYSTEM
Field of the Invention
The present invention relates to a sample measurement system. In particular the invention relates to a sample measurement system for measuring certain selected properties of a liquid substrate, such as the glucose levels in a blood sample. The invention also relates to a sampling plate, a measurement device, an adaptor allowing the sampling plate to communicate with the measurement device, a data carrier containing software to operate the measurement device, a method of manufacturing a sampling plate, a continuous sheet having a plurality of sampling plates, a method of manufacturing a continuous sheet, and an apparatus for manufacturing a continuous sheet.
Description of the Background Art
There is a widespread need for sample measurement systems such as those enabling a diabetes patient to know their blood sugar levels -i.e. the concentration of glucose in their blood.
At present, numerous systems exist having a measurement device which receives and reads a sampling plate spotted with a blood sample from a diabetes patient.
The sampling plate is typically rectangular and is end-loaded with the blood sample. The blood sample, once loaded, is drawn into a sample zone having a number of testing zones. The sample is sequentially drawn past a first testing zone, following by a second, and then a third until all testing zones have received the sample.
Each testing zone has its own particular contents.
For example, the first testing zone has glucose oxidase, the second a mixture of glucose oxidase and a predetermined amount of glucose. The third testing zone is blank. As the blood sample is drawn over all three testing zones, chemical reactions occur with the contents of each testing zone, resulting in discrete electrolytes.
Each testing zone bridges a corresponding pair of electrodes. A potential difference is established across each testing zone, via the electrodes, when the sampling plate is inserted into an operating measurement device.
Electric current readings for each testing zone then provide measurements necessary to assess the blood sugar (glucose) levels. For instance, the first testing zone gives the primary measurement, whereas the second testing zone provides a degree of calibration since a known quantity of glucose was already present therein. The third zone gives a final check by acoounting for the non-glucose contribution to the measurements in the first and second testing zones.
A good example of the system described above is disclosed in WO 2008/029110. The sampling plates of such systems are formed by screen printing techniques.
A problem with such a system is that the sampling plate is end-loaded, with a loading port at one end.
Therefore, the loading port is small, and often difficult to use, particularly for the elderly or infirm. Sampling plates are also necessarily thicker to accommodate this arrangement.
Another problem with the system is that there is a high degree of batch to batch variation with the manufacture of the sampling plates, which creates the problem of numerous "performance bands". Each batch of plates is thus sold bearing a performance band number, which the patient must input into the measurement device before measurements are taken. Incorrect input of the sampling plate performance band number into the measurement device leads to inaccurate measurements. This can happen if a patient forgets to input the correct performance band number when taking a first sampling plate from a new pack of sampling plates, or the patient does not understand the importance of the performance band number. Severely inaccurate results can lead to the need for healthcare intervention.
Another problem is that the measurements are generally inaccurate even where the performance band is entered correctly, and the measurements are properly calibrated.
This is due in part to inherent inaccuracy in the manufacturing process of the sampling plates, particularly in respect of the electrodes, and their corresponding testing zones. Inaccuracies also arise due to the sampling technique, which exposes a sample destined for the third testing zone to conditions in the other two testing zones, as it travels along a fluid path.
Furthermore, the entire blood sample when drawn over the three testing zones remains as a single continuous sample rather than three discrete samples, since the three samples are linked by blood remaining in the fluid path.
This can cause interference between testing zones, which is a particular problem where electrochemical and optical (reflectance and absorbance) measurements are involved.
Further accuracy problems arise owing to the inaccurate and inconsistent dosing of the contents of each testing zone. For instance, enzymes are generally deposited on to a testing zone as an ink in a paste-like form. Such pastes are difficult to lay down with any degree of volumetric or positional accuracy.
Another problem is that it is difficult to facilitate uniform division of the blood sample between or to each testing zone, which again gives rise to inaccuracies in the ultimate measurements.
Another problem is that the measurements are displayed by the measurement device in such a way that some patients do not know what the measurements mean or how to interpret the information. Furthermore, such sample measurement systems only allow the measurement of a single property, such as glucose content.
Another problem is that the manufacturing process for the sampling plates is inefficient, with low useable throughput and high product reject rates.
It is an object of the present invention to provide an improved sample measurement system and method of manufacture thereof.
Summary of the Invention
In accordance with a first aspect of the present invention there is provided a sample measurement system for performing electrochemical measurements on a sample, the system comprising: a sampling plate with a loading port for receiving a liquid substrate; and a measurement device; wherein the sampling plate comprises a sample zone with at least two discrete testing zones, which sample zone is arranged, in use, to separate the liquid substrate into at least two discrete samples, such that each sample occupies a respective testing zone; and the measurement device is operable to communicate with the sampling plate to measure one or more selected properties of any of the at least two samples.
Herein, "to separate the liquid substrate into at least two discrete samples" means to actively separate the liquid substance into and maintain separation of discrete samples.
The invention has the advantage that separation of the liquid substrate into discrete samples is automatic.
Furthermore, the separation forms "discrete" samples, i.e. samples which are fully separated from each other. In particular, they are not linked together by a portion of the liquid substrate which may, for instance, otherwise remain on a fluid path between the at least two discrete samples. Discrete samples, rather than samples which overlap, allows for greater accuracy in measurements. The invention also has the advantage that each of the at least two discrete samples is exposed to only one testing zone, thereby avoiding contamination or interference by another testing zone, which may otherwise lead to inaccurate measurements.
The invention allows multiple measurements to be taken in respect of a plurality of discrete samples. For example, one sample may be used to determine one selected property (e.g. physiological condition); another sample may be used to determine another selected property. The measurements may pertain to the same property or different properties, thus allowing for detailed analysis of a liquid substance, such as a patient's blood, using a single sampling plate.
Preferably the system in accordance with the present invention is operable to take an electrochemical measurement in respect of each sample. The system may have three or more testing zones, preferably from three to five testing zones, most preferably four testing zones.
The presence of multiple testing zones and samples allows for determination and/or quantification of different metabolites, assessment of different physiological conditions, averaging of measurement results, and validation of measurement results.
The liquid substrate may be blood, for instance, from a diabetic patient. In this case, blood glucose levels may be measured.
It will be understood that the present invention does not exclude multiple loading ports and multiple sampling of different liquid substances. However, preferably a single liquid substance is received by the sampling plate having only one loading port.
The sampling plate may be a strip, such as a flexible strip, or a rigid plate. Preferably the sampling plate is a substantially rigid plate.
The sample zone preferably comprises a hydrophobic zone or boundary (hereinafter hydrophobic boundary) which, in use, lies between the at least two testing zones. A preferred hydrophobic material is flexographic ink, preferably doped with at least one component which increases hydrophobicity, e.g. a detergent. This is advantageous as the hydrophobic boundary separates samples, and/or assists in the separation of the liguid substance into discrete samples.
Each of the at least two testing zones preferably comprises a hydrophilic portion, which is arranged to receive one of the at least two discrete samples. A preferred hydrophilic material is flexographic ink, preferably doped with at least one component which increases hydrophilicity. Surface tension tends to keep each sample in its own testing zone.
Each testing zone preferably comprises a well, where each well is arranged to receive one of the at least two discrete samples. The well may be circular or non-circular, and is preferably non-circular, preferably substantial sguare shaped. Preferably the well has sides where the sides are substantially sloped. Preferably the sides connect to a base of the well and to a top sheet (in which the well is formed) in a smooth or continuous manner, without any discontinuities. The well preferably has a surface area of between 2.5 and 4 mm and a depth of 200-300 pm. Each well may ccmprise the abcvementioned hydrophilic porticn. A well helps to keep the samples discrete, and also provides a three dimensional target for dosing inks thereinto (see below) . This improves the manufacturing process.
Preferably the wells contain a pair of spaced electrodes and the electrical bridge between the electrodes is made when a sample enters the wells.
Preferably all of the testing zones are, in use, employed for providing measurements of a sample contained therein. However, one or more of the at least two testing zones may serve an alternative purpose, such as to collect excess liquid substrate to avoid the other testing zones from becoming overfilled.
The sample zone may therefore help separate the liguid substance into discrete samples by virtue of its shape.
This may include paths. This may also include troughs, recesses, etc., herein broadly referred to as wells. The sample zone may also help separate the liquid substance by virtue of chemical means. For instance, the sample zone may comprise certain hydrophobic region(s) and/or hydrophobic region(s) . Preferably the sample zone helps to separate the liguid substance into discrete samples by virtue of both its shape and the chemical means.
The sampling plate may comprise a spreading means for assisting distribution of the samples to their respective testing zones. In some embodiments, the spreading means may comprise a mesh over the sample zone. Such a mesh may permit the liquid substance to pass therethrough into the at least two testing zones. The mesh helps to spread the liquid substance uniformly over the sampling zone as a whole, and particularly helps spread the liquid substance uniformly over the two or more testing zones.
The mesh may comprise a mixture of mesh hydrophobic and mesh hydrophilic materials. The mesh is preferably cross-hatched. The mesh may comprise parallel strands of hydrophobic material and at least partially orthogonal but parallel strands of hydrophilic material. Alternatively, parallel strands may be alternately hydrophobic and hydrophilic. Provision of hydrophilic material in the mesh helps to spread the liquid substrate. Provision of hydrophobic material in the mesh helps repel the liquid substrate into the testing zones. The mesh may therefore have a top face coated with hydrophilic material, and a bottom face coated with hydrophobic material.
The loading port is preferably arranged on a top face of the sampling plate. Such a top-fill arrangement is preferable to an end-fill, where the loading port is on an edge of the sampling plate. This is because the top-fill arrangement is more accessible for loading a liquid substance, especially for those with reduced dexterity such as the elderly or infirm. Furthermore, sampling plates may be thinner in profile where they are arranged for top-filling. Preferably the loading port is arranged directly above or over the sample zone. This means that the liquid substance once loaded at the loading port, is delivered to the sample zone, possibly assisted by gravity. This is preferable, for instance, over delivery along a fluid path by pure capillary action, which relies on a continuous feed of the liquid substance until the sample zone is suitably supplied with liquid substance.
Such pure capillary action delivery requires a greater amount of the liquid substance, e.g. blood, given that some of the liquid substance always remains along the fluid path between the loading port and the sample zone.
Such an arrangement also allows gravity to assist or cause splitting and/or delivery of the liquid substance into the at least two testing zones. This helps to ensure that each sample forms within its respective testing zone as a fully discrete sample, rather than being linked to other samples by liquid substance remaining along a fluid path.
Therefore, a top-fill sampling plate, which also has a hydrophobic boundary, allows splitting of a single liquid substance into at least two discrete samples using both physical and chemical means.
Where a mesh is present, the mesh is preferably disposed between the loading port and the sample zone.
The loading port is preferably circular. Preferably the loading port has an area of between 5 and 10 mm2.
Preferably the loading port comprises an opening in a covering tape.
At least one of the at least two testing zones preferably comprises a laid-down material, which in the medical testing field is conventionally called an "ink" (this term is used hereinafter) . The ink may have a pigment, but not necessarily. Preferably the ink comprises a test material, so as to be an "active" ink.
Preferably the test material is selected to be chemically reactive with at least one component of the liquid substrate. This reactivity may provide the basis for measurements of a selected property of the liquid substance. The test material is preferably bound to the testing zone, so as not to flow during normal handling of the sampling plate. The test material is preferably dried on to the testing zone, and may be a dried coating, gel or paste. Preferably it is formed from a liquid precursor, preferably a solution of the test material. The test material within the ink is preferably selected to be chemically reactive with glucose. However, the test material may also be selected to be reactive with another component of the liquid substance, such as ketones. The test material preferably comprises an enzyme, preferably either glucose oxidase or glucose dehydrogenase.
Preferably more than one of the at least two testing zones comprises an ink. Each ink may be different or comprise a different test material. Each different ink may react with the same component, so as to provide measurements which are self-calibrating. Alternatively each different ink may react with a different component of the liquid substance, enabling measurement of a plurality of selected properties. Measurement of a plurality of selected properties allows assessment and/or monitoring of a plurality of different illnesses, conditions, and/or medical states (analyte levels/concentration) . It also allows assessment or monitoring of such as recreational drug use, or alcohol abuse. In particular it allows assessment of the use of a plurality of recreational drugs simultaneously.
Preferably at least one testing zone comprises a "mediator" ink. The mediator ink is conductive when in solution or mixed with a liquid substance such as blood.
This increases the sensitivity of the measurements. The same at least one testing zone preferably further comprises either an active ink or a passive ink. The active ink comprises a test material, whereas the passive ink is the same as the active ink but without the test material. The mediator ink and active or passive ink may be substantially mixed with each other, rather than being layered. This can be achieved by pre-mixing the inks before laying them down in the at least one testing zone.
The sampling plate preferably comprises at least one pair of electrodes connectable to electrical terminals within the measurement device. A pair of electrodes generally consists of an anode/cathode pair. The at least one pair of electrodes is preferably bridged by the liquid substrate in one of the at least two testing zones. In use, that testing zone preferable contains an electrolyte, where the electrolyte is preferably one of the at least two samples, and is more preferably the reaction product of one of the at least two samples with an ink. The measurement device suitably communicates with the sampling plate by applying a potential difference across the at least one pair of electrodes. Such communication preferably provides measurements in respect of the electrolyte to determine certain one or more selected properties of the liquid substance. Such an electrochemical measurement technique is typically more accurate than other sample measurement techniques available in the field, such as optical measurements.
Preferably, after loading the liquid sample, the system requires a period of time, preferably from 3 to 15 seconds, before the result is made available.
A pair of electrodes per testing zone does not exclude an embodiment where all or some testing zones have a single common electrode, whether a cathode or an anode.
Such a common electrode has a plurality of termini (electrolyte contacts) adjacent to or in each testing zone. In this case each testing zone associated with the common electrode preferably has its own individual opposite electrode, whether an anode or cathode. In fact, a single common electrode arrangement is preferred owing to ease of manufacture of both the sampling plate and the corresponding measurement device.
The electrolyte is preferably producible by a chemical reaction between at least one component of the liquid substrate and the ink. Selected properties may be measurable from an electric current measurement. A constant potential difference, preferably between 100 and 1000 millivolts (my), through the at least one pair of electrodes and across a corresponding testing zone may give rise to an electric current, which current is dependent on the selected property, e.g. glucose concentration. In some embodiments it is believed that the anode and cathode actually cause a chemical reaction.
In other embodiments the anode and cathode are believed not to cause a chemical reaction.
The sampling plate or precursor therefor preferably comprises a first flexographic print layer. The flexographic print layer may be either a complete layer or a partial layer. Preferably the sampling plate comprises a second flexographic print layer, preferably printed relative to the first. Preferably the sampling plate comprises subsequent flexographic print layers, also printed relative to the first. The position of second and subsequent print layers are preferably all relative to registration points on a precursor sheet. More preferably the sampling plate comprises a plurality of flexographic print layers printed at a single discrete processing station.
Preferably the first flexographic print layer or plurality of flexographic print layers are on a platform.
The platform may be polymeric, preferably a polyvinylchloride (PVC) precursor sheet or plate, but is preferably comprised of paper-based material, such as card. The platform is preferably coated with a lacquer.
The platform preferably comprises on at least one side at least one flexographic print layer. The first flexographic print layer may be a hydrophilic layer, preferably covering substantially the entire surface of the platform. Such use of paper-based material is an environmentally friendly alternative to a PVC platform.
It also reduces dependency on oil-based materials, which are more exposed to price fluctuations.
Flexographic print layers are highly advantageous in relation to sampling plates of the present invention.
Flexographic manufacturing allows for high throughput and great accuracy of printing, particularly in relation to three dimensional surface structure. This in turn provides for more accurate measurements of samples.
Flexographic printing is furthermore, a highly consistent manufacturing technique giving little batch to batch or intra-batch variation. This goes some way to alleviating the need for "performance bands" used with traditional sampling plates. A sampling plate can be categorised as having a particular performance band based on its manufacturing batch information. A performance band is an indication of the performance level of a particular sampling plate. Traditionally, each sampling plate is sold with packaging information that includes a performance band number which is to be inputted into the measurement device before measurements are made. This calibrates a given sampling plate based on its performance band (see below) to allow meaningful measurements to be made regardless of the sampling plate used. Flexographic print layers are, however, so accurate that few (preferably a maximum of 3) or no performance bands are required, thus simplifying the manufacture and operation of the measurement device.
The sampling plate preferably comprises a flexographically printed electrode (or printed circuit board) . Furthermore, the sampling plate preferably comprises a flexographically printed sample zone, preferably including any hydrophobic boundaries and/or hydrophilic portions/wells. This again provides accurately manufactured sampling plates which give more accurate sampling and consequently more accurate measurements.
The ink is preferably a high-precision dosed ink.
This again provides for more accurate measurements, and reduces batch to batch or intra-batch variation. High-precision dosing preferably involves dosing an ink, such as an enzyme, as a mobile solution, preferably a solution with a density of about 1 g/mL, but preferably at most 2g/mL. Preferably the solution comprises ethanol as a solvent. This avoids the dosing problems associated with using pastes of the ink. Preferably the high-precision dosed ink has a dose volume between 100 nL and 150 nL, and is dosed with a tolerance of +1-5 nL or better. The dose volume is the volume of the dosed ink solution. Drying will remove most of the volume after dosing.
The sampling plate may comprise an information tag, readable by an information tag reader associated with the measurement device. The information tag may include, but is not limited to, product authentication information.
This may prevent harmful circulation/use of counterfeit sampling plates. The information tag preferably comprises a performance indicator, arranged to communicate with the measurement device. The measurement device therefore preferably comprises a performance indicator reader (preferably comprised of the information tag reader) to read the performance indicator. Preferably the performance indicator is for automatic performance band calibration. This avoids the need for a user to input a performance band into the measurement device before taking measurements. The performance indicator is preferably a performance band transmitter arranged to communicate with a performance band receiver comprised of the measurement device. Preferably the transmitter is a radio freguency transmitter such as an RFID tag (radio-frequency identification tag) The measurement device is preferably arranged to receive the sampling plate without adaptation. The measurement device preferably operates pursuant of software. The software is preferably arranged to be compatible with the sampling plate without adaptation or modification. The software preferably precludes the use of other sampling plates outside the scope of the present invention with the measurement device, without an authentication signal. Such an authentication signal may be provided to the measurement device by an adaptor. Such an authentication signal may be received and/or validated by the information tag reader.
The sample measurement system may further comprise an adaptor to allow the measurement device to communicate with the sampling plate. The adaptor may allow a sampling plate of the present invention to be adapted for use with a traditional measurement device. In this case such a traditional measurement device may serve only as a display device to display measurement results, which measurement results are generated by the adaptor itself. In such a case, the adaptor itself may comprise an information tag reader, preferably comprising a performance indicator reader. The performance indicator reader may receive performance band information from the performance indicator of the sampling plate, and use such information to calibrate measurement results before sending the results to be displayed on the traditional measurement device. Compatibility with old measurement devices may be important for a smooth transition to using the technology of the present invention, as the measurement devices are more expensive than the sampling plates. Furthermore, patients often prefer to keep a measurement device with which they are already familiar.
Alternatively, the adaptor may also allow traditional sampling plates to be used with the measurement device of the present invention. In this case, the adaptor may itself comprise an information tag which communicates information about the traditional sampling plate to the information tag reader.
The measurement device preferably comprises a data carrier, which data carrier comprises software arranged to control the measurement device. The measurement device may be configured to display a variety of information and/or measurements pertaining too the liquid substance.
Furthermore, the configuration may be customised. The measurement device may comprise a computer. The sampling plate may be arranged or adapted by the adaptor to be connectable with the computer, for example, via a USIB port.
In accordance with a second aspect of the present invention there is provided a sampling plate as described in the first aspect.
In accordance with a third aspect of the present invention there is provided a measurement device as described in the first aspect. The measurement device is preferably arranged to receive the sampling plate of either the first or second aspect without adaptation, for instance with an adaptor. The measurement device may be handheld.
In accordance with a fourth aspect of the present invention there is provided an adaptor as described in the first aspect. The adaptor may be connectable between the measurement device and any other sampling plate, or the sampling plate and any measurement device. The adaptor may comprise electrical connectors (contacts) to connect the at least one pair of electrodes of the sampling plate to a power source or terminals within the measurement device.
In accordance with a fifth aspect of the present invention there is provided an adaptor for connecting any sampling plate (not necessarily as defined in the first aspect) to any measurement device (not necessarily as defined in the first aspect) . The adaptor may comprise a processor for managing two-way communication between the sampling plate and measurement device, which may otherwise be incompatible.
In accordance with a sixth aspect of the present invention there is provided a data carrier as described the first aspect.
In accordance with a seventh aspect of the present invention there is provided a method of manufacturing a sampling plate (preferably but not necessarily as defined in the first aspect) for receiving a liquid substrate, comprising: flexographically printing at least one layer upon the sampling plate.
The at least one layer may be a partial layer, or alternatively a substantially complete layer. The method preferably comprises flexographically printing one or more of: a hydrophilic layer, at least one pair of electrodes, insulation for the at least one pair of electrodes, a hydrophobic layer, decorative artwork. The sampling plate is preferably arranged to receive a blood sample.
The method preferably further comprises flexographically printing a plurality of layers upon the sampling plate. The method preferably comprises flexographically printing a plurality of layers upon the sampling plate at a single discrete processing station.
This enables high throughput whilst retaining manufacturing precision.
The method preferably comprises producing at least two three dimensional wells in the sampling plate arranged in use to retain a sample of the liguid substrate. The at least two wells are preferably produced immediately prior to or immediately after flexographically printing any layers on the sampling plate. Preferably the at least two wells are produced in the same manufacturing process step as the flexographic printing. Preferably the at least two wells are produced after flexographically printing the at least one pair of electrodes. Each well preferably corresponds with a discrete testing zone.
The method preferably comprises flexographically printing at least one pair of electrodes upon the sampling plate. The method preferably further comprises flexographically printing an insulation layer over a substantial part of the at least one pair of electrodes.
Preferably printing of the insulation layer leaves a terminal contact for each electrode to be connectable to terminals of an electrical power source, and also leaves an electrolyte contact which ensures the electrodes are connectable, in use, to an electrolyte upon the sampling plate.
The method preferably oomprises flexographioally printing a sample zone with at least two disorete testing zones arranged, in use, to separate the liquid substrate into at least two disorete samples, suoh that eaoh of the at least two disorete samples 000upies one of the at least two testing zones. The method preferably further oomprises flexographioally printing a hydrophobio boundary upon the sample zone, whioh hydrophobio boundary is arranged, in use, to keep the at least two disorete samples oompletely separate, in oorresponding disorete testing zones. The flexographio printing of the hydrophobio boundary is preferably around eaoh of the testing zones, and also preferably around eaoh of the at least two three-dimensional wells.
The method preferably comprises dosing an ink selected to be chemically reactive with at least one component of the liquid substrate to at least one of the at least two testing zones. Preferably the dosing involves dosing the ink as a solution comprising a solvent. Preferably the viscosity of the solution is about 0.8 to 1.2 mPa.s.
Preferably the solvent comprises ethanol.
The method may comprise attaching a mesh to the sampling plate, preferably to cover the sample zone, or all of the at least two testing zones.
The method preferably comprises attaching a covering tape to the sampling plate. Preferably there is an aperture in the covering tape corresponding to the position of a loading port for loading the sample.
The method may oomprise attaohing an information tag, whioh preferably oomprises a performanoe indioator, to the sampling plate. Preferably the performanoe indioator is an RFID tag (a radio frequenoy identifioation tag) . The performanoe indioator preferably oontains batoh speoifio information, preferably information about the performanoe band of any partioular sampling plate. The method may therefore further oomprise testing a sampling plate from a batoh of sampling plates to establish the performanoe band of a partioular batoh or part of a partioular batoh.
The method may oomprise outting the sampling plate from a oontinuous sheet oomprising a plurality of sampling plates. Preferably outting is guided by at least one registration point formed upon either a sampling plate or elsewhere on the oontinuous sheet. Preferably there are a series of registration points. Preferably the at least one registration point is flexographioally printed.
In aooordanoe with a eighth aspeot of the present invention there is provided a method of manufaoturing a oontinuous sheet oomprislng a plurality of sampling plates, the method oomprising: produoing a first sampling plate, by the method of the seventh aspeot upon a oontinuous sheet; produoing a seoond sampling plate adjaoent to the first sampling plate, upon the oontinuous sheet.
The method preferably further oomprises forming a first and seoond registration point on the oontinuous sheet, eaoh oorresponding with the first and seoond sampling plates. The registration points preferably allow an apparatus for producing sampling plates to reference the position of each sampling plate. Preferably the method comprises forming a series of registration points on the continuous sheet.
The method preferably comprises making perforations in the continuous sheet around the first and second sampling plates. The perforations are arranged to assist cutting or separating sampling plates.
The method may further comprise cutting the continuous sheet. Cutting preferably separates the first sampling plate from the second sampling plate. Cutting may leave a smaller continuous sheet with a plurality of sampling plates, such as a card of sampling plates.
According to a ninth aspect of the present invention there is provided a continuous sheet comprising a plurality of sampling plates, as produced by the method of the eighth aspect. The continuous sheet may be a card or sheet of sampling plates cut from a larger continuous sheet.
According to a tenth aspect of the present invention there is provided an apparatus for carrying out the method of the eighth aspect and for producing the continuous sheet of the ninth aspect.
According to a eleventh aspect of the present invention there is provided a method of testing a medical condition comprising: a) loading a liquid substanoe from the body to a sampling plate of the first or seoond aspeot; b) operating a measurement device, of the first or third aspeots, to oommunioate with the sampling plate to measure one or more seleoted properties of the liquid substanoe.
The method preferably oomprises testing diabetes. The method may oomprise testing for the presenoe of one or more reoreation drugs, and may inolude tests for alcohol.
The method may oomprise testing oardiao oonditions, suoh as elevated adrenalin levels. Potentially any oondition whioh oauses a ohange in oonoentration of a oomponent in the blood (indioative ohemistry) may be tested for.
Aooording to an twelfth aspeot of the present invention there is provided a diagnostio kit for testing a medical oondition, oomprising the sampling plate and the measurement devioe.
Preferred features of one aspeot of the present invention are also preferred features of any other aspeot.
Brief Desoription of the Drawings For a better understanding, the present invention is now desoribed with reference to the following diagrammatic drawings, in which: Figure 1 is a projection view of a sample measurement system according to an exemplary embodiment; Figure 2 is a top projection view of a sampling plate according to the exemplary embodiment of Figure 1; Figure 3 is a top projection of internal components of the sampling plate of Figure 2; Figure 4 is a top view of a sample zone of the sampling plate of Figure 2; Figure 5a is a projection view of a sample measurement system according to another exemplary embodiment; Figure Sb is a projection view of a sample measurement system according to another exemplary embodiment; Figure Sc is a projection view of a sample measurement system according to another exemplary embodiment; Figure 6 is a flow diagram overview of the method of producing a sampling plate; Figure 7 is an expanded flow diagram of Step 1 of Figure 6; Figure 8 is an expanded flow diagram of Step 2 of Figure 6; Figure 9 is an expanded flow diagram of Step 3 of Figure 6; Figure 10 is a top view of a oard produoed from Step 3 of Figure 6; and Figure 11 is an expanded flow diagram of Step 4 of Figure 6.
Detailed Description of Exemplary Embodiments
The exemplary embodiments will now be discussed in detail in relation to an improved sample measurement system, and method of manufacture thereof. In particular the following embodiment relates to a system with a sampling plate for sampling a liquid substance, particularly blood, and a measurement device for measuring selected properties of the blood, particularly glucose levels. This system is especially applicable to a diabetes patient monitoring blood sugar levels.
Figure 1 is a projection view of a sample measurement system according to an exemplary embodiment, and shows a sampling plate 100 inserted into a measurement device 200.
The sampling plate 100 has a loading port 110 for receiving a blood sample on a top face of the sampling plate 100. Directly below the loading port 110 is a sample zone 120 having four discrete testing zones 122, which in this example are three dimensional wells 122.
Each well 122 is 250 pm deep, is 1.5 mm wide, and 1.5 mm long. In this example, each of the four wells 122 contains an ink 124. Three of the wells contain an active ink along with a mediator ink. The mediator helps conductivity, and the active ink contains a test material selected for its reactivity with glucose in the blood. In this example, the active ink contains glucose dehydrogenase. The remaining well contains a passive ink along with the mediator ink, where the passive ink is identical to the active ink but without the glucose dehydrogenase. In another embodiment at least one of the wells is spiked with a known quantity of glucose. This assists calibration when conducting measurements. The measurement device 200 has a plate port 210 into which the sampling plate 100 is inserted, and a screen 220 for displaying results, measurements, and/or other desirable data.
Furthermore, the sampling plate 100 has a performance indicator 150. The performance indicator 150 contains information about the sampling plate which, in this example, is transmittable to the measurement device 200.
The measurement device 200 has a performance indicator reader (not shown) which reads the information from the performance indicator 150. In this example the performance indicator 150 is an RFID tag which transmits calibration data to the performance indicator reader (a radio frequency receiver) . The calibration data relates to the quality of the sampling plate ("performance bands"), for which there can be variation from batch-to-batch or intra-batch. The measurement device 200 then automatically corrects measurements based on the calibration data received to ensure that measurements are consistent from plate to plate, regardless of batch/intra-batch variation.
Figure 2 is a top projection view of the sampling plate 100, and in addition to Figure 1 shows a covering tape 105, having an aperture 110 corresponding with the loading port 110, and a series of electrodes 130, the ends (terminal contacts 136) of which connect to electrical terminals within the measurement device 200 to allow measurements to be taken.
Figure 3 is a top projection of internal components of the sampling plate, and shows the electrodes which, in this example, are formed as a printed circuit board. There is a central single common electrode 132 common to all four wells 122. Four individual electrodes 134 join each well. In this example the common electrode 132 is a cathode, and the four individual electrodes 134 are anodes. Each electrode has a terminal contact 136, and an electrolyte contact 138. Each well 122 bridges a gap between each pair of electrodes 130, specifically between a pair of electrolyte contacts 138, where each pair consists of the common electrode 132 and an individual electrode 134. When an electrolyte is present in any of the four wells 122, a current can flow through its corresponding pair of electrodes 132, 134 when the sampling plate 100 is inserted into the measurement device 200 and the measurement device 200 is operated. In this example a four-channel circuit may be produced, enabling four sets of electrochemical measurements on a single sampling plate. The terminals within the measurement device 200 provide a potential difference (voltage) of between 400 and 500 mV. The measured current (microamps) is then proportional to the concentration of glucose within a given blood sample. The sampling plate also comprises a electrical switch bar 139, which acts as a switch to turn on the measurement device 200 when the sampling plate 100 is inserted thereinto.
Figure 4 is a top view of the sample zone 120 of the sampling plate 100. The sample zone 120 has wells 122 made of hydrophilic material, each well 122 being separated from each other well 122 by a hydrophobic boundary 128. In one embodiment, overlaying the sample zone 120 is a cross-hatched mesh 140. The mesh 140 is made from a mixture of hydrophilic and hydrophobic materials, and in this embodiment has a small clearance from the wells 122 to avoid the mesh 140 dipping into any samples received by the wells 122. The mesh 140 is designed to assist in the uniform distribution of the blood sample. In an alternative embodiment there is no mesh. Alternatively other structures may be incorporated to achieve the effect of distribution/dividing the sample.
Figures 5a, Sb, and Sc are projection views of a sample measurement system according to alternative exemplary embodiments. In each case, a sampling plate 100 is connected to a measurement device 200 via an adaptor 300. In each case, the sampling plate is not directly compatible with the measurement device (i.e. not designed to fit directly into the plate port 210) . The adaptor 300 has a plate end 310 (or plate insertion end) designed to receive the sampling plate 100. The plate end 310 has electrical contacts which receive and connect with the terminal contacts 136 of the sampling plate electrodes 130. The adaptor 300 has a device end 320 arranged to simulate a sampling plate which fits directly into the measurement device, and therefore has electrical contacts (pins) arranged to link the electrodes 130 of the sampling plate 100 to corresponding electrical terminals within the measurement device 200. Within the adaptor is a processor which manages the two-way communication between the sampling plate 100 and the measurement device 200.
Emodiments of the adaptor 300 enable compatibility between various sampling plates 100 and measurement devices 200.
Figure 5a shows the measurement device 200 of the embodiment of Figure 1 adapted to receive an otherwise incompatible sampling plate 100. Figure Sb shows the sampling plate 100 of the embodiment of Figures 1 to 4 adapted to fit into an otherwise incompatible measurement device 200. Figure Sc shows a sampling plate 100 (not of the previous embodiment) adapted to fit into an otherwise incompatible measurement device (not of the previous embodiment) It will be understood that where the measurement device 200 is a traditional device or other device not arranged or adapted in accordance with the invention, such a device 200 will not have a performance indicator reader, but may still be capable of providing accurate measurements from the sampling plate 100 where the "performance band" is inputted manually into the measurement device.
The measurement device 200 of either embodiment of Figure 1 or 5 has a data carrier containing software. The data carrier may also receive and store data, such as measurements. The measurement device 200 operates pursuant to the software. The software has a default setting which takes current (microamps) measurements from three of the four channels. In this example, the measurement device 200 uses multiplexing to measure each of the four channels separately and sequentially. In other examples measurements from all four channels are taken simultaneously. "Multiplexing" is where a cycle of pulse measurements are taken from each channel in turn before repeating the cycle. In this case, multiplexing occurs at approximately 50 Hz. The data is processed and the results are displayed on the screen 220. In this example the results are indicative of blood glucose levels. Results may be displayed as raw data, or as Thigh", "low", etc. Messages relating to the new test result and how it compares to the patient's personal parameters will be displayed. Measurement devices 200 applicable to the present invention are well described in Wa 2008/029110, along with their operation.
The measurement device 200 according to the embodiments of both Figure 1 and 5 can interface with an ordinary personal computer to allow the raw data to be processed in a customised manner. This furthermore allows unigue presentation of the results. The device 200 is simply connectable to a computer as a standard external disc drive.
The sample measurement systems described above are simple to use. The following procedure is employed: 1. The diabetic patient inserts a new test strip 100 into the plate port 210.
2. The measurement device 200 then prepares for receiving measurements and conducts system checks (approximately 3 seconds) 3. The device 200 reguests the patient to apply a blood sample to the sampling plate 100.
4. The patient applies a blood sample to the sampling plate 100 via the loading port 110.
5. The device 200 takes measurements for approximately 5 to 10 seconds.
6. The device performs calculations, statistical manipulations, and displays measurement results and accuracy levels.
7. The measurement results and accuracy levels are stored in the device's 200 memory.
In this example the deivce 200 switches on as soon as the plate 100 is inserted into the port 210, by virtue of the switch bar 139.During step 4, the sampling plate 100 automatically separates the blood into the four discrete wells 122. The optional mesh 140 spreads the blood substantially uniformly across the sample zone such that blood samples drip from the mesh 140 under gravity into their respective wells 122. The hydrophobic boundary 128 also ensures that any blood dripping thereupon is directed towards the hydrophilic wells 122, using both surface tension and gravity.
Where the mesh is absent, the sample zone performs all the separation and spreading work itself.
The device 200 processes the measurements in view of the calibration data from the RFID tag 150, and also internally calibrates and/or performs accuracy level calculations from the measurements taken from each of the wells 122. Internal calibration is effected by the use of statistical algorithms based on the inks and components of the blood which are the subject of measurement.
Statistical algorithms are also used to establish the accuracy level of the measurements taken. The screen 220 then displays the result either as raw data, such as blood sugar concentration, or as Thigh" or "low", depending on the user's preference. The device 200 also displays the accuracy level. Messages relating to the new test result and how it compares to the patient's personal parameters will be displayed.
Results are calculated on the basis of current decay across a particular well as measured over 5 to 10 seconds.
The rate of decay provides an indication of blood glucose levels.
In this example the measurement device 200 also displays, on the screen 220, an accuracy level or an error message if the accuracy level is outside a predefined range. Regulation dictates that blood glucose measurement systems must provide test results with a minimum accuracy level. Thus the predefined range will always comply with regulatory standards. Thus any results with an accuracy outside these limits will give rise to an error message, indicating that the test should be repeated.
In this example, the sampling plates 100 are produced as follows.
Figure 6 is a flow diagram overview of a method of producing a sampling plate from a continuous sheet. The diagram shows the method being carried out at four processing stations, including: Step 1: A flexographic printing station 400; Step 2: A precision dosing station 500; Step 3: A card finishing station 600; and Step 4: A strip cutting and vialing station 700.
A continuous sheet in the form of a continuous roll is fed into the flexographio printing station 400. In this example, the continuous sheet is supplied with a surface that is hydrophilic in nature. Alternatively a hydrophilic coating may be applied at the beginning of the flexographic printing process. The output of step 1 is a smaller continuous sheet, in this example a card having sampling plates (strips), arranged as 8 rows of 25 strips. Inks are then precisely dosed during step 2 at the precision dosing station 500. Step 3 involves finishing the card by applying additional layers at the card finishing station 600. Finally Step 4, at the strip cutting and vialing station 700, involves cutting the card to provide individual strips ready for use and packaging sets of strips in vials.
Figure 7 is an expanded flow diagram of Step 1 of Figure 6, and shows the flexographic printing process at the flexographic printing station 400 in more detail. The flexographic printing station 400 comprises a plurality of in-line flexographio print modules and further process modules. A continuous roll 101 is first fed into a first flexographio print module 410 for printing the electrodes and registration points. There is a registration point at regular intervals along the roll 101. The roll then proceeds to a surface deformation module 420, where four three-dimensional wells 122 are formed, in respect of each strip 100 on the roll, using a roller tool set. The roll then proceeds to a second flexographio print module 430, where the insulation layer is printed over the electrodes, so as to leave terminal contacts 136 and electrolyte contacts 138. At a third flexographio print module 440, the hydrophobic boundary 128 is printed around the wells 122. At a fourth flexographic print module 450, a first decorative artwork colour is flexographically printed in respect of each strip 100 on the roll 101. At a fifth flexographic print module 460, a second decorative artwork colour is printed. Optionally there may be additional flexographic print modules for printing additional artwork. Such flexographic printing allows for high resolution images small enough to be printed on a sampling plate 100. Such images may provide simple information or alternatively enhance product aesthetics, or include branding etc. The roll then proceeds to an edge trimming module 470, where edges of the roll 101 are trimmed based on the positions of the registration points.
The roll then enters a perforating module 480, where accurately aligned micro-perforations are applied to the roll along an edge of each row of strips. Finally the roll enters a card cutting module 490 where the roll is cut to produce a number of cards 102, which are deposited in a first card collector 492. Each card contains two hundred strips (8 rows of 25 strips) . The roll 101 proceeds through the flexographio printing station 400 on conveyer rollers 402 until it is cut into cards 102. Each flexographic print module has a flexographic unit and a drier. The printing of an individual layer is accurate to +/-30 micrometers. Print layer on print layer accuracy is +/-50 micrometers. The throughput through the flexographic printing station 400 is generally about 300 meters/mm.
Figure 8 is an expanded flow diagram of Step 2 of Figure 6, and shows the precision dosing process at the precision dosing station 500 in more detail. Here inks are nano-dosed (120 nL +/-5 nL per ink) with volumetric and positional preoision, with eaoh well 122 oreating an exoellent three-dimensional target for eaoh ink. Chemioal solutions of the inks are produoed, in this example, with ethanol as solvent. A oard 102 from Step 1 is first introduoed to a first dosing unit 510, where an ink solution oontaining a mixture of a mediator ink and an aotive ink is dosed into one well 122 per strip 100 on the oard 102. It should be noted that embodiments whioh use the same ink in more than one well per strip may have eaoh suoh well dosed with the same ink at the same dosing unit.
The oard 102 is then dried in a first drying unit 512 The oard 102 prooeeds to a seoond dosing unit 520 where another ink solution of mediator/aotive ink is dosed to another well 122 per strip 100 on the oard 102, The oard is then again dried in a seoond drying unit 522. Finally the oard 102 prooeeds to a third dosing unit 530 where yet another ink solution of mediator/aotive ink is dosed to a further well 122 per strip 100 on the oard 102. The oard is then dried in a third drying unit 532 and deposited in a seoond oard oolleotor 540. Optionally a fourth ink solution may be dosed into a further well, whioh ink solution oontains a mediator/passive ink. In this embodiment the aotive ink oontains gluoose dehydrogenase.
However, in other embodiments the aotive ink may be different to allow measurements relating to a oondition other than diabetes. Alternatively the aotive inks present may be different from eaoh other to allow simultaneous measurements relating to a plurality of oonditions. It is during the preoision dosing that different inks may be dosed depending on the measurements ultimately desired. For instanoe, dosing one ink for measuring gluoose levels, and another for measuring ketone levels is easily aohievable.
Figure 9 is an expanded flow diagram of Step 3 of Figure 6, and shows the card finishing process at the card finishing station 600 in more detail. Figure 10 is a top view of a card produced at the card finishing station 600.
The card finishing station 600 applies three further materials to the card 102: a mesh 140, a covering tape 105, and RFID tags 150 (radio-frequency identification strips) . Figure 10 also shows the registration points 103 spaced at regular intervals on the card 102. In Step 3 a card 102 from Step 2 is transferred to a machine bed of the card finishing station 600. In an embodiment which incorporates the mesh the card 102 is conveyed to a mesh-laying unit 610 with a card vision and position system 612. The vision system 612 establishes the precise location of the card 102. The card position system corrects the position of the card relative to the mesh-laying unit 610. The unit 610 places cross-hatched mesh ribbons 140 across the strips 100. A single mesh ribbon 140 is laid along a single row of strips 100. The mesh ribbons are anchored by ultrasonic welding before they are cut from feed rolls of the mesh ribbon 140. In another embodiment, this mesh-laying step is omitted. In yet another embodiment, the mesh-laying step is replaced by a step Incorporating another structure or component which achieves the same effect as the mesh. The card 102 is then taken along the machine bed to a hotmelt pattern laying unit 620, where another vision system 622 pinpoints the location of the card before a hotmelt application head moves across the card 102. The card is then conveyed to a covering tape-laying unit 630. Lanes of covering tape 105 are positioned above the mesh ribbons 140. Another vision system 632 controls roll out of the covering tape 105 50 as to correctly align a hole in the tape 105 with the loading port 110 and sample zone 120 of each strip 100.
Downward pressure and heat is then applied to secure the covering tapes 105 before they are cut from their respective feed rolls. The card is then conveyed to an RFID ribbon-laying unit 640, where a vision system 642 again controls the positioning of the RFID ribbon 150 and again corrects the card position with a position system before downward pressure is applied to secure the RFID ribbon 150. The RFID ribbon 150 is self-adhesive and is placed near to the terminal contacts 136 at an end of the strip 100 which is connectable to the measurement device 200. Once the RFID ribbons 150 are cut from their feed rolls to leave RFID tags 150 on each strip 100, the card 102 then proceeds to a third card collector 650. At this stage the performance band of the batch of test strips is determined by destructively testing 1% of all finished cards 102 in a testing unit 660. The testing unit applies a precisely dosed glucose solution to each well 122 of a strip 100 taken from a card 102, and takes measurements to obtain a card's 102 performance profile data. This data is uploaded to a production control database and stored as part of a batch record. The data is then recalled in Step 4 (see below) . The mesh ribbons 140 are positioned with an accuracy of +/-200 micrometers or better, relative to the registration points on the card 102. The hotmelt pattern is positioned with an accuracy of +1-200 micrometers. The covering tape is positioned with an accuracy of +/-100 micrometers, as is the positioning of the hole in the tape relative to the loading port 110.
The RFID ribbons are positioned with an accuracy of +1-micrometers.
Figure 11 is an expanded flow diagram of Step 4 of Figure 6, and shows the strip outting and vialing prooess at the strip outting and vialing station 700 in more detail. A finished oard 102 is transferred from Step 3 to an input traok of the station 700. The oard is first taken to an RFID programming unit 710, where eaoh of the RFID tags 150 assooiated with eaoh strip is programmed by retrieving the performanoe profile data obtained in Step 3 from the batoh reoord database. The data is imparted to the RFID tags 150 to be later read by the measurement devioe 200 when a patient inserts a strip 100 thereinto.
The programmed oard 102 is then taken to a row-outting unit 720 where eaoh oard 102 is divided into 8 separate rows along the perforations. Suoh perforations help the aoouraoy of outting, and therefore reduoe the space needed between rows, thereby inoreasing the number of sampling plates per square meter. Wear and tear of the outter is also reduoed. Each oard 102 has a waste area at either end. This waste area is removed as part of the row-outting prooess and the waste is colleoted for disposal.
The separated rows are colleoted and transferred to a strip outting unit 730 where lasers (or alternatively knives) are used to oonvert eaoh row into 25 individual strips 100. Eaoh row has an area of waste material at eaoh end, whioh is suitably removed and disposed of at the strip outting unit 730. Closed vials are then introduoed to the outting and vialing station 700 via a vial hopper 740. Vials are transferred and orientated before being presented for filling. A filling system 750 opens eaoh vial and plaoes up to 25 strips therein before closing the vial. The vials of strips are stored until distribution requests are received. At this point the vials are retrieved and packaged with all necessary labelling, user guides, information, particularly information on performance bands. The strips are then ready for distribution. Row cutting is carried out with an accuracy of +1-100 micrometers. Strip cutting is carried out with an accuracy of +/-100 micrometres.
The original continuous roll 101 is made of paper-based material (i.e. card) . In this example the card is coated with a lacquer. Alternatively, however, the roll 101 could be of polymer based materials, such as PVC or polycarbonate.

Claims (13)

  1. CLAIMS: 1. An adaptor for oonneoting a sampling plate for reoeiving a liquid substrate to be tested to a measurement devioe operable to display, or to both measure and display, one or more seleoted properties of the liquid substrate.
  2. 2. An adaptor as olaimed in olaim 1, wherein the adaptor oomprises a prooessor for managing two-way oommunioation between the sampling plate and the measurement devioe, whioh are otherwise inoompatible.
  3. 3. An adaptor as olaimed in olaim 1 or 2, wherein the sampling plate oomprises a sample zone with at least two disorete testing zones, whioh sample zone is arranged, in use, to separate the liquid substrate into at least two disorete samples, suoh that eaoh sample 000upies a respeotive testing zone.
  4. 4. An adaptor as olaimed in olaim 1, wherein the measurement devioe is operable to oommunioate with the sampling plate to measure and / or display one or more seleoted properties of the liquid substrate, the adaptor having an information tag whioh oommunioates information about the sampling plate to the measurement devioe.
  5. 5. An adaptor as olaimed in olaim 1, wherein the measurement devioe oomprises a data oarrier, whioh data oarrier oomprises software arranged to oontrol the measurement devioe.
  6. 6. an adaptor as claimed in claim 1, in which the adaptor permits connection between a sampling plate which comprises a sample zone with at least two discrete testing zones, which sample zone is arranged, in use, to separate the liquid substrate into at least two discrete samples, such that each sample occupies a respective testing zone, and a measurement device which serves only as a display device to display measurement results, wherein the adaptor comprises an information tag reader and, in use, sends results to be displayed to the measurement device.
  7. 7. An adaptor as claimed in claim 1, wherein the adaptor is arranged to be connectable with a computer.
  8. 8. An adaptor as claimed in claim 7, wherein it is arranged to be connectable via a USB port.
  9. 9. A sample measurement system comprising a sampling plate, a measurement and / or display device and an adaptor as claimed in any of claims 1 to 8.
  10. 10. A sample measurement system as claimed in claim 9, wherein the sampling plate comprises a sample zone with at least two discrete testing zones, which sample zone is arranged, in use, to separate the liquid substrate into at least two discrete samples, such that each sample occupies a respective testing zone, and the measurement device may be a measurement device intended for use with a different sampling plate.
  11. 11. A sample measurement system as claimed in claim 9 or 10, for measuring one or more properties of blood.
  12. 12 A sample measurement system as claimed in claim 11, for measuring the glucose level in blood.
  13. 13. An adaptor substantially as hereinbefore described with reference to Figs. 5a) to Sc) of the accompanying drawings.
GB1205054.8A 2008-09-30 2008-09-30 Sample measurement system Expired - Fee Related GB2486842B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1205054.8A GB2486842B (en) 2008-09-30 2008-09-30 Sample measurement system
HK12113388.9A HK1172683A1 (en) 2008-09-30 2012-12-27 Sample measurement system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1205054.8A GB2486842B (en) 2008-09-30 2008-09-30 Sample measurement system

Publications (3)

Publication Number Publication Date
GB201205054D0 GB201205054D0 (en) 2012-05-09
GB2486842A true GB2486842A (en) 2012-06-27
GB2486842B GB2486842B (en) 2013-06-12

Family

ID=46086942

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1205054.8A Expired - Fee Related GB2486842B (en) 2008-09-30 2008-09-30 Sample measurement system

Country Status (2)

Country Link
GB (1) GB2486842B (en)
HK (1) HK1172683A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK201500541A1 (en) * 2015-09-13 2017-03-27 Pro-Ino Dev Aps Handheld apparatus for testing a sample of body fluid
DK201500540A1 (en) * 2015-09-13 2017-03-27 Pro-Ino Dev Aps Handheld apparatus for testing a sample of prepared food for allergens and/or food intolerance ingredients
CN110609072A (en) * 2019-10-17 2019-12-24 南京工业大学 Weak signal detection circuit of Prussian blue membrane bioelectrode

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1357194A2 (en) * 2002-04-26 2003-10-29 Matsushita Electric Industrial Co., Ltd. Adapter for the connection of a biosensor to a measuring device
WO2003094713A1 (en) * 2002-05-14 2003-11-20 Mediventure Co., Ltd. Blood sugar tester and data uploading method
WO2005047877A1 (en) * 2003-11-07 2005-05-26 Bionime Electrochemical sensing device
WO2005079664A1 (en) * 2004-02-19 2005-09-01 Edward Henry Mathews Blood glucose monitor for mobile communication device
EP1723412A1 (en) * 2004-03-05 2006-11-22 Egomedical Swiss AG Analyte test system for determining the concentration of an analyte in a physiological fluid
EP1764030A1 (en) * 2005-09-20 2007-03-21 F. Hoffmann-La Roche AG Blood glucose measurement device
WO2007076940A1 (en) * 2005-12-30 2007-07-12 Roche Diagnostics Gmbh Portable analytical device
WO2008134587A1 (en) * 2007-04-27 2008-11-06 Abbott Diabetes Care, Inc. Test strip identification using conductive patterns
GB2465842A (en) * 2008-12-05 2010-06-09 Accunostics Ltd Adaptor for an analyte measuring device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2610294C (en) * 2005-05-09 2023-10-03 Theranos, Inc. Point-of-care fluidic systems and uses thereof

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1357194A2 (en) * 2002-04-26 2003-10-29 Matsushita Electric Industrial Co., Ltd. Adapter for the connection of a biosensor to a measuring device
WO2003094713A1 (en) * 2002-05-14 2003-11-20 Mediventure Co., Ltd. Blood sugar tester and data uploading method
WO2005047877A1 (en) * 2003-11-07 2005-05-26 Bionime Electrochemical sensing device
WO2005079664A1 (en) * 2004-02-19 2005-09-01 Edward Henry Mathews Blood glucose monitor for mobile communication device
EP1723412A1 (en) * 2004-03-05 2006-11-22 Egomedical Swiss AG Analyte test system for determining the concentration of an analyte in a physiological fluid
EP1764030A1 (en) * 2005-09-20 2007-03-21 F. Hoffmann-La Roche AG Blood glucose measurement device
WO2007076940A1 (en) * 2005-12-30 2007-07-12 Roche Diagnostics Gmbh Portable analytical device
WO2008134587A1 (en) * 2007-04-27 2008-11-06 Abbott Diabetes Care, Inc. Test strip identification using conductive patterns
GB2465842A (en) * 2008-12-05 2010-06-09 Accunostics Ltd Adaptor for an analyte measuring device

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK201500541A1 (en) * 2015-09-13 2017-03-27 Pro-Ino Dev Aps Handheld apparatus for testing a sample of body fluid
DK201500540A1 (en) * 2015-09-13 2017-03-27 Pro-Ino Dev Aps Handheld apparatus for testing a sample of prepared food for allergens and/or food intolerance ingredients
DK178966B1 (en) * 2015-09-13 2017-07-10 Pro-Ino Dev Aps Handheld apparatus for testing a sample of prepared food for allergens and/or food intolerance ingredients
DK178995B1 (en) * 2015-09-13 2017-07-31 Pro-Ino Dev Aps Handheld apparatus for testing a sample of body fluid
CN108291888A (en) * 2015-09-13 2018-07-17 普罗-伊诺发展有限公司 Handheld apparatus for testing humoral sample
CN110609072A (en) * 2019-10-17 2019-12-24 南京工业大学 Weak signal detection circuit of Prussian blue membrane bioelectrode
CN110609072B (en) * 2019-10-17 2020-04-17 南京工业大学 Weak signal detection circuit of Prussian blue membrane bioelectrode

Also Published As

Publication number Publication date
GB201205054D0 (en) 2012-05-09
GB2486842B (en) 2013-06-12
HK1172683A1 (en) 2013-04-26

Similar Documents

Publication Publication Date Title
US20110174618A1 (en) Sample measurement system
RU2461002C2 (en) Embossed cell analyte sensor and method of manufacture
US8894832B2 (en) Sampling plate
US9011658B2 (en) Sampling plate
EP2414825B1 (en) Biosensor with predetermined dose response curve and method of manufacturing
US20090214384A1 (en) Identification of a strip type by the meter using conductive patterns on the strip
CN101715554A (en) no calibration analyte sensors and methods
CN101517402A (en) Analyte sensors and methods
GB2463914A (en) Test strip for glucose monitoring with discrete testing zones
GB2486842A (en) Adaptor for connecting a sampling plate to a measurement device
AU2011236589A1 (en) Sampling plate
AU2011234226A1 (en) Sampling plate

Legal Events

Date Code Title Description
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1172683

Country of ref document: HK

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20140930